Application 075862
- Type
- ANDA
- Sponsor
- BARR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | TABLET;ORAL-21 | 0.02MG;0.1MG | No | No |
| 002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | TABLET;ORAL-28 | 0.02MG;0.1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075862-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | 0.02MG;0.1MG | TABLET / ORAL-21 | 2003-04-29 | ||
| A075862-002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | 0.02MG;0.1MG | TABLET / ORAL-28 | 2003-04-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075862-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-21 | 2003-04-29 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A075862-002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-28 | 2003-04-29 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075862-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-21 | 2003-04-29 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075862-002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-28 | 2003-04-29 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075862-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-21 | 2003-04-29 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075862-002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-28 | 2003-04-29 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075862-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-21 | 2003-04-29 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075862-002 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-28 | 2003-04-29 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 44fbc5ae-5682-471f-a12a-955e8b4d233a | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | Levonorgestrel and Ethinyl Estradiol |
| levonorgestrel and ethinyl estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 3d87d9a4-860a-4ea7-a993-0f4adf1789da | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | levonorgestrel and ethinyl estradiol |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 6e686b50-8d36-4a13-91a8-d4ad21cdb735 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | Levonorgestrel and Ethinyl Estradiol |
| levonorgestrel and ethinyl estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Acella Pharmaceuticals | 167b12a0-cdff-4081-a0a4-164482c239fa | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | levonorgestrel and ethinyl estradiol |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 35eb35e6-d9a0-4472-94ac-aa470ccba567 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | Levonorgestrel and Ethinyl Estradiol |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | ea9f7216-0358-43a9-96eb-5dad694ae9b8 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | Levonorgestrel and Ethinyl Estradiol |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | f1a3bfe0-1057-4120-be7e-d7b3570d5418 | 2024-04-22 | Warnings, Adverse reactions | Levonorgestrel and Ethinyl Estradiol |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | LEVONORGESTREL AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | c3c00dc0-8834-45fb-9f5b-810a98cef59d | 2022-08-31 | Boxed warning, Warnings, Adverse reactions | LEVONORGESTREL AND ETHINYL ESTRADIOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.